These results strongly suggest that higher IL-23R+ T cells and higher IL-17+ T cells (both CD4+ and CD8+ subsets) are one of the characteristics exhibited by SLE patients and may be useful biomarkers for detection of severity and disease stage in SLE patients. Here, IL23R is linked to systemic lupus erythematosus.